UK Markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
76.61-0.62 (-0.80%)
At close: 4:02PM EDT
Full screen
Loading interactive chart…
  • Yahoo Finance Video

    Affordable Care Act survives third Supreme Court challenge

    Andy Slavitt, former White House COVID-19 Response Team adviser, author of ‘PREVENTABLE: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response’, joins Yahoo Finance to discuss the COVID-19 response in the U.S. and the Supreme court upholding the Affordable Care Act.

  • This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market
    Motley Fool

    This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market

    After a long year and a half spent enduring the coronavirus pandemic, signs of normalcy are starting to show in many U.S. businesses and communities, thanks in part to pharmaceutical breakthroughs including vaccines. After two previously failed attempts to develop new antiviral treatments, biopharma giant Merck (NYSE: MRK) has come up with something it believes will provide care for those in need. Specifically, Merck has been collaborating with Ridgeback Biotherapeutics on a clinical development program for molnupiravir, an oral antiviral medication.

  • Merck to Participate in the Guggenheim Biopharma Strategy Series
    Business Wire

    Merck to Participate in the Guggenheim Biopharma Strategy Series

    KENILWORTH, N.J., Jun 17, 2021--Merck to Participate in the Guggenheim Biopharma Strategy Series